Get in Touch



SL-2402

Selexipag, 98%

CAS No. : 
[475086-01-2]    
MDL No. : 
MFCD10567093
Synonyms : 2-(4-((5,6-Diphenylpyrazin-2-yl)(isopropyl)amino)butoxy)-N-(methylsulfonyl)acetamide; ACT-293987; NS-304

Price and Availability
Pack Size Price in USD Quantity Availability Shipping Status
5MG100.00 In Stock Available to Ship on 04.27.2024
10MG150.00 In Stock Available to Ship on 04.27.2024
50MG350.00 In Stock Available to Ship on 04.27.2024
100MG450.00 In Stock Available to Ship on 04.27.2024
250MG980.00 In Stock Available to Ship on 04.27.2024
Chemical Properties
C26H32N4O4S 496.62
Pale yellow solid Not available
DMSO
For Laboratory research use only, not for drug, household or other uses.
Applications : Selexipag is an orally available and potent agonist for the Prostacyclin (PGI2) receptor (IP receptor).
References : Kuwano K. et al.: J. Pharmacol Exp Ther., 322 (3), 1181-1188, 2007; Mous D.S. et al.: Am. J. Physiol Lung Cell Mol Physiol., May 10, 2018.
Storage : Keep container tightly closed under nitrogen or argon and refrigerate for long-term shelf life.
Caution : In case of contact with skin or eyes, rinse immediately with plenty of water and seek medical advice. Wear suitable protective clothing and gloves.

To receive price and delivery information on larger quantities, please complete the form below and we will respond promptly.

If you login prior to completion of the form, your contact information will automatically populate.

Your request for quote will also be accepted by e-mail at sales@syninnova.com or Fax: +1 780 485 2963.

Product ID : SL-2402

Product Name : Selexipag

Note : If you do not find your required compound in our catalogue, or not commercially available, please contact us, we will assist you to get your desired molecule. We only charge if we deliver to your satisfaction.

Site is under construction and it will coming soon. Please contact us at sales@syninnova.com for COA. Thank you!

Site is under construction and it will coming soon. Please contact us at sales@syninnova.com for HNMR. Thank you!